NASDAQ: MREO INVESTOR ALERT: Berger Montague Advises Mereo BioPharma Group PLC (NASDAQ: MREO) Investors of an April 6, 2026 Deadline
PHILADELPHIA, Feb. 18, 2026 /PRNewswire/ — National plaintiffs’ law firm Berger Montague PC announces that a class action lawsuit has been…
